DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 55 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $1,123,000 | -33.9% | 114,945 | +129.9% | 0.04% | -21.2% |
| Q3 2021 | $1,699,000 | -62.6% | 50,000 | -50.6% | 0.05% | -59.7% |
| Q1 2021 | $4,538,000 | +226.0% | 101,200 | +146.8% | 0.13% | -45.8% |
| Q3 2019 | $1,392,000 | -9.9% | 41,000 | -39.8% | 0.24% | -63.2% |
| Q4 2017 | $1,545,000 | +16.3% | 68,154 | -2.6% | 0.65% | +66.1% |
| Q3 2017 | $1,329,000 | – | 70,000 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |